FDA Says Ambien Dosage is to Be Lowered for Women

The U.S. Food and Drug Administration issued a statement on Thursday revealing its decision to require that the makers of zolpidem, a common sleep aid drug, reduce the dosage that is given to patients, particularly women. The FDA issued the mandate due to the emergence of information that has shown that the drug can stay in a person’s system for several hours after they wake up.